Fiona Robinson: NBDF Webinar Explores the Practical Challenges of Hemophilia Gene Therapy
Fiona Robinson, Medical Writer and Editor at Communications Fiona Robinson, shared National Bleeding Disorders Foundation’s post on LinkedIn:
“Last week we learned about the promise of gene therapy, so can everyone with hemophilia just get it?
Of course, it’s not that simple.
In this week’s National Bleeding Disorders Foundation Wednesday Webinar Dr Diane Nugent, Social Worker Jessica Wulf, and Jeff Blake from Hemophilia Alliance will discuss some of the Challenges of Gene Therapy, including eligibility, access, insurance, advocacy, and psychosocial aspects.
Bring your questions for the live Q and A!
2PM ET, Nov 4.”
National Bleeding Disorders Foundation shared a post on LinkedIn:
“The Challenge of Gene Therapy.
Speakers: Diane Nugent, Jeff Blake, Jessica Wulf, LMSW
Gene therapy offers exciting possibilities for people living with hemophilia B, but the journey to treatment is long, complex, and full of obstacle.
Join our expert panel as we discuss eligibility requirements, insurance challenges, advocacy efforts, and the psychosocial factors that influence treatment decisions.
Attendees will gain practical insights and resources to help navigate the evolving gene therapy landscape.
Plenty of time will be alloted for a live Q and A.”

Other posts featuring Fiona Robinson on Hemostasis Today.
-
Nov 10, 2026, 16:28Can the VWF to ADAMTS-13 Ratio Predict Mortality in Sepsis-Induced Coagulopathy? – RPTH Journal
-
Nov 10, 2026, 16:28Ruth Willems: PhD Defence at Maastricht University on Thrombosis and Bleeding in HPB Disease
-
Nov 10, 2026, 16:09Edward Lee Carter: Factor XIa Inhibition Enters Clinical Practice
-
Nov 10, 2026, 16:08Edward C.C. Wong: Deriving Ferritin Cutoffs for Iron Deficiency Using RBC Parameters
-
Nov 10, 2026, 16:07Milad Abdalla: Decoding Hemoglobin Electrophoresis – A Practical Diagnostic Reference
-
Nov 10, 2026, 15:13Wolfgang Miesbach: Nonviral Gene Therapy for Haemophilia A Using Lipid Nanoparticles
-
Nov 10, 2026, 15:06Dahra Teles: First Speaking Experience at HEMO 2026 on First-Line Multiple Myeloma Treatment
-
Nov 10, 2026, 14:55Yazan Abou-Ismail: First FDA-Approved Factor XIa Inhibitor for Stroke Prevention
-
Nov 10, 2026, 14:49Ifeanyichukwu Ifechidere: The Role of Coagulation in Anaesthesia and Surgery